Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Cochran's Q Test01:17

Cochran's Q Test

Cochran's Q Test is a nonparametric statistical test used to determine if there are potential differences in the outcomes of three or more related groups on a binary (yes/no) or dichotomous outcome. It is essentially an extension of the McNemar Test, which is limited to two related samples - Cochran's Q test can handle three or more related samples, making it more versatile in scenarios where subjects are measured under multiple conditions. The test statistic follows a Chi-Square distribution,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Newborn Screening for Hemoglobinopathies and Thalassemias: Brief History, Recent Activities, and Global Status-2026.

International journal of neonatal screening·2026
Same author

Newborn Screening for Hemoglobin Disorders.

Clinics in perinatology·2025
Same author

Consolidated Newborn Bloodspot Screening Efforts in Developing Countries in the Asia Pacific-2024.

International journal of neonatal screening·2025
Same author

Development, Validation, and Application of the Paya Hamsan Technologies Underivatized Newborn Screening Assay (PHUNSA) for Inborn Metabolic Disorders in Dried Blood Spot Samples from Iranian Infants.

International journal of neonatal screening·2025
Same author

Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020-2023).

International journal of neonatal screening·2024
Same author

Newborn Screening Long-Term Follow-Up Clinics (Continuity Clinics) in the Philippines during the COVID-19 Pandemic: Continuing Quality Patient Care.

International journal of neonatal screening·2023

Related Experiment Video

Updated: Jun 18, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Considerations in choosing screening conditions: one (US) approach.

Bradford L Therrell1

  • 1Department of Pediatrics, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. therrell@uthscsa.edu

Annals of the Academy of Medicine, Singapore
|November 12, 2009
PubMed
Summary

The United States lacks a national newborn screening policy, leading to varied state guidelines. This report details the development of national recommendations for newborn screening tests and selection criteria.

More Related Videos

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Related Experiment Videos

Last Updated: Jun 18, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Area of Science:

  • Genetics
  • Public Health
  • Pediatrics

Background:

  • The United States has 51 distinct newborn screening (NBS) policies due to the absence of a national strategy.
  • A 2000 American Academy of Pediatrics report proposed a national blueprint for NBS.
  • This led to federal initiatives to standardize NBS practices nationwide.

Purpose of the Study:

  • To outline the development of a national decision-making algorithm for selecting conditions for NBS panels.
  • To present the recommended panel of screening tests for state implementation.
  • To summarize the processes and outcomes guiding current US NBS recommendations.

Main Methods:

  • A working group developed a national NBS blueprint.
  • The Health Resources and Services Administration contracted the American College of Medical Genetics.
  • An algorithm for condition selection and a recommended test panel were created.

Main Results:

  • Development of a systematic algorithm for choosing NBS conditions.
  • Establishment of a recommended panel of screening tests for national guidance.
  • Summarization of the collaborative process leading to current NBS standards.

Conclusions:

  • The developed algorithm and recommended panel provide a framework for consistent NBS across the US.
  • These efforts aim to improve early detection and management of genetic disorders in newborns.
  • The report synthesizes the foundational work for current US newborn screening recommendations.